| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Jasper gets a lifeline in merger with immune drugmaker Kira | ||
| Fr | GSK shelves cough drug acquired in $2B deal | ||
| Fr | Arbutus, Sanofi escalate mRNA patent fights; InnoCare's TYK2 contender advances | ||
| Fr | How well are AI-discovered drugs faring in the clinic? | ||
| Do | Lilly to buy AtaiBeckley for $2.8B, further validating psychedelics | ||
| Do | Veradermics keeps 'momentum going' as baldness drug helps women with hair loss | ||
| Do | Merck wins first approval of a PCSK9 cholesterol pill | ||
| Mi | Celcuity gains FDA approval for closely-watched breast cancer drug | ||
| Mi | Braveheart, Attovia join next wave of biotech IPOs | ||
| Mi | Merck ADC, in China study, shows potential to replace chemo in lung cancer | ||
| Mi | J&J dips despite upbeat outlook; AstraZeneca, Spero cut China deals | ||
| Di | CVS Caremark reaches settlement with FTC over insulin suit | ||
| Di | Judge orders Apple Tree partner to forfeit oversight of venture fund | ||
| Di | Fresh off buyout, Akero execs reunite to advance long-acting psoriasis pill | ||
| Di | Draig bags another $65M to speed testing of brain drugs | ||
| Di | Biogen data highlight promise, questions surrounding tau-targeting Alzheimer's drugs | ||
| 13.07. | Freenome colorectal cancer test data improve on earlier results | ||
| 13.07. | Q32 bounces back to claim study success for alopecia drug | ||
| 13.07. | Agenus surges on study pivot; Apnimed lines up an IPO | ||
| 13.07. | Biotech startup funding gap widens despite rebound in VC investment | ||
| 10.07. | GSK, Hansoh ADC extends survival in lung cancer study | ||
| 10.07. | ARPA-H puts $160M into bespoke drug therapies; Biohaven switches up scientific leadership | ||
| 09.07. | Roche scraps two Ionis-partnered Huntington's drugs | ||
| 09.07. | GSK ends brain drug alliance with Alector | ||
| 09.07. | HHS plan to speed drug research won't remove 'self-inflicted' delays |